Global, regional and national burden of Parkinson's disease in people over 55 years of age: a systematic analysis of the global burden of disease study, 1991-2021
- PMID: 40269818
- PMCID: PMC12016353
- DOI: 10.1186/s12883-025-04191-8
Global, regional and national burden of Parkinson's disease in people over 55 years of age: a systematic analysis of the global burden of disease study, 1991-2021
Abstract
Background: Parkinson's disease (PD) has emerged as a major global public health challenge. However, there is currently a lack of systematic analysis regarding the burden of PD and its long-term trends among people over 55 years of age.
Methods: This study utilizes data from the Global Burden of Disease 2021 database to analyze the prevalence, incidence, disability-adjusted life years (DALYs), and mortality rates of PD in individuals aged 55 and older from 1990 to 2021. The annual percentage change was calculated to assess the temporal trends of the disease burden. Point estimates and their corresponding ranges were reported with 95% uncertainty intervals.
Results: Globally, the prevalence, incidence, DALYs, and mortality rates of PD in individuals aged 55 and above significantly increased from 1990 to 2021, with all indicators being higher in males than in females. This trend was evident across all five Socio-Demographic Index (SDI) groups and in 21 regions worldwide. The number of prevalent cases, incident cases, DALYs, and deaths all showed significant increases and were positively correlated with SDI (R = 0.645, P < 0.001). Among 185 countries, the incidence rate increased, with DALY rates rising in 74 countries and mortality rates rising in 65 countries. Notably, in the population aged 95 years and older, the prevalence and incidence of PD showed particularly remarkable increases, at 735% and 505%, respectively. Furthermore, the greatest increase in prevalence was observed in the 55-59 age group, especially in countries with Middle SDI and High-middle SDI regions.
Conclusions: This study indicates that the burden of PD in individuals aged 55 and above has significantly increased over the past three decades. This trend reflects the profound impact of global aging and socioeconomic development levels on the burden of PD, underscoring the urgency of addressing PD as a major global public health challenge.
Keywords: Epidemiological trends; Global burden of disease; Middle-aged and elderly populations; Parkinson's disease; Socio-demographic index.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–72. - PubMed
-
- Ahmad MH, Rizvi MA, Ali M, Mondal AC. Neurobiology of depression in Parkinson’s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev. 2023;85:101840. - PubMed
-
- Tanner CM, Ostrem JL. Parkinson’s disease. N Engl J Med. 2024;391(5):442–52. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
